Healthy, Hypertension
Conditions
Keywords
Cardiovascular, Caffeine, L-citrulline, Arterial Function, Hemodynamics, Blood Pressure, Pulse Wave Velocity, Pulse Wave Analysis
Brief summary
Caffeine is an exceedingly popular and consumed pharmacological agent. Although caffeine is primarily consumed from coffee and tea beverages, it is also available in other forms such as sodas, energy drinks, tablets and capsules. Nevertheless, caffeine acutely increases brachial and aortic systolic blood pressure (BP) and arterial stiffness. Arterial stiffness is an independent predictor of cardiovascular disease (CVD) and assessed through pulse wave velocity (PWV). Interestingly, previous studies have proposed that caffeine may increase aortic BP through increases in aortic PWV and augmentation index (AIx), a measurement of wave reflection. Yet, these effects were seen in middle-aged adults with treated hypertension and a wide age range. Therefore, it is imperative to consider that caffeine may cause different effects in young normotensive individuals than in older adults independently of BP levels. Importantly, oral supplementation of the amino-acid, L-citrulline has been shown to enhance the bioavailability of L-arginine levels and nitric oxide (NO) production and, therefore, improve arterial function. L-citrulline supplementation for 7 days given at 6 g/day has shown to increase NO levels while improving PWV. Previous studies by our group also demonstrated that L-citrulline supplementation reduces the BP response to cold exposure; a condition with an increased vasoconstriction. Therefore, the acute effects of caffeine on central and peripheral PWV and BP in healthy young men are yet to be fully evaluated. We hypothesized that acute caffeine intake would increase peripheral and aortic BP and PWV and that L-citrulline supplementation would attenuate the effects induced by acute caffeine ingestion.
Detailed description
The specific aims of this study are: AIM 1: To examine the effects of the acute ingestion of 200mg caffeine (tablets) on arterial function in young adults. The working hypothesis is that acute caffeine intake would increase brachial, ankle and aortic BP, PWV (aortic and leg), and wave reflection. In order to test this hypothesis, the investigators will perform non-invasive measurements of arterial stiffness (aortic and leg PWV) and pulse wave analysis (aortic BP and AIx) using applanation tonometry of the radial artery 30, 45, and 60 minutes following caffeine ingestion. AIM 2: To determine the effectiveness of L-citrulline supplementation to attenuate the acute cardiovascular effects of caffeine ingestion. The working hypothesis is that 7 days of L-citrulline supplementation will attenuate the unfavorable arterial responses (increases in BP, PWV, and wave reflection) to acute caffeine ingestion. In order to test this hypothesis, the investigators will perform the same procedures previously specified in AIM 1. Description of the study: Sixteen healthy young men 18-40 years of age will be enrolled in this study. Participants with CVD history, resting BP (\> 160/100 mmHg), recent history of smoking, or considered competitive athlete will be excluded from the study. All subjects will refrain from food and caffeine for \> 8 hours and from exercise for \> 24 hours before testing. Study design: Following an initial screening, arterial function measurements will be collected. Measurements will be assessed at baseline following 10 minutes of rest in the supine position and then again at 30, 45, and 60 minutes after 200 mg caffeine or placebo ingestion. Participants will receive caffeine or placebo supplementation on two separate visits with a minimum of 48 hours in between sessions. Following the acute phase of the study, subjects will be randomized to consume L-citrulline or placebo for 7 days given at 6 grams/day. Following the same protocol as the acute phase with 200 mg caffeine, measurements will be collected before and after the 7 day supplementation period.
Interventions
A 200 mg caffeine tablet was given to subject to examine the drugs effect on arterial function.
A 750 mg placebo capsule (maltodextrin) was given to subjects to examine the effect of the drug on arterial function.
L-citrulline was used to examine the effect of the supplement on arterial function.
Sponsors
Study design
Eligibility
Inclusion criteria
* Young healthy males * Non smoker * Non endurance trained athlete * No previous history of cardiovascular disease
Exclusion criteria
* Female * Blood pressure greater than 160/100 * Smoker
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Aortic Blood Pressure | Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points) | Aortic blood pressure at rest and 30 minutes after acute ingestion of 200 mg of caffeine before and after 7 days of either 6g/day of Citrulline or 6 g/day of Placebo. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Reflected Wave Pressure (P2) | Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points) | Reflected wave pressure at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo. |
| Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day) | Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points) | Femoral-ankle pulse wave velocity at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo. |
Participant flow
Recruitment details
Sixteen young healthy men participated in this study. All subjects were non-smokers, recreationally active, and free of apparent cardiovascular-metabolic diseases based on medical history.
Pre-assignment details
Of the 42 individuals screened, 16 individuals completed the intervention in its entirety.
Participants by arm
| Arm | Count |
|---|---|
| L-Citrulline or Placebo Placebo and L-Citrulline pills produced by NOW FOODS, USA
Citrulline or Placebo (both 6g/day) were given for a 7 day supplementation period. This was followed by a 14 day washout period and crossover to the other supplement (L-Citrulline or Placebo) for 7 days. Measurements of arterial function were performed to determine if the supplements had any significant effect on blood pressure control/pressure wave reflection at rest and immediately after ingestion of 200 milligrams of caffeine. | 16 |
| Total | 16 |
Baseline characteristics
| Characteristic | L-Citrulline or Placebo | — |
|---|---|---|
| Age, Categorical <=18 years | 0 Participants | — |
| Age, Categorical >=65 years | 0 Participants | — |
| Age, Categorical Between 18 and 65 years | 16 Participants | — |
| Age, Continuous | 23 years STANDARD_DEVIATION 3 | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Sex: Female, Male Female | 0 Participants | — |
| Sex: Female, Male Male | 16 Participants | — |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Aortic Blood Pressure
Aortic blood pressure at rest and 30 minutes after acute ingestion of 200 mg of caffeine before and after 7 days of either 6g/day of Citrulline or 6 g/day of Placebo.
Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)
Population: Young, apparently healthy individuals, aged 18-40 years old.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Citrulline | Aortic Blood Pressure | Baseline | 5 mmHg | Standard Deviation 1 |
| Citrulline | Aortic Blood Pressure | 7 Days | 4 mmHg | Standard Deviation 1 |
| Placebo | Aortic Blood Pressure | Baseline | 6 mmHg | Standard Deviation 1 |
| Placebo | Aortic Blood Pressure | 7 Days | 4 mmHg | Standard Deviation 1 |
Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)
Femoral-ankle pulse wave velocity at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.
Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)
Population: young, apparently healthy adults, aged 18-40 years
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Citrulline | Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day) | Baseline | 0.6 m/s | Standard Deviation 0.4 |
| Citrulline | Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day) | 7 Days | 0.4 m/s | Standard Deviation 0.4 |
| Placebo | Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day) | Baseline | 0.7 m/s | Standard Deviation 0.5 |
| Placebo | Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day) | 7 Days | 0.6 m/s | Standard Deviation 0.4 |
Changes in Reflected Wave Pressure (P2)
Reflected wave pressure at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.
Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)
Population: Young, apparently healthy adults, aged 18-40 years.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Citrulline | Changes in Reflected Wave Pressure (P2) | Baseline | 5 mmHg | Standard Deviation 1 |
| Citrulline | Changes in Reflected Wave Pressure (P2) | 7 Days | 4 mmHg | Standard Deviation 1 |
| Placebo | Changes in Reflected Wave Pressure (P2) | Baseline | 5 mmHg | Standard Deviation 1 |
| Placebo | Changes in Reflected Wave Pressure (P2) | 7 Days | 5 mmHg | Standard Deviation 1 |